Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.

Aspira Women’s Health Stock Performance

Aspira Women’s Health stock opened at $0.72 on Monday. Aspira Women’s Health has a 1 year low of $0.67 and a 1 year high of $5.65. The firm’s 50-day moving average is $0.79 and its 200-day moving average is $0.98. The company has a market cap of $12.00 million, a P/E ratio of -0.60 and a beta of 1.39.

Institutional Investors Weigh In On Aspira Women’s Health

An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co acquired a new position in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned 0.19% of Aspira Women’s Health at the end of the most recent quarter. 12.19% of the stock is owned by institutional investors.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.